Product Information
CLOBETASOL PROP 0.05% FOAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.4050 per GM under NDC 68462060827. Its NADAC has been published 387 times since May 8, 2019.
FDA first approved this application on Feb 15, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462060827
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA210809FDA Approved
2/15/2019
TE Code
AB1
On Market Since
2/16/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL PROP 0.05% FOAM has been published 387 times since May 8, 2019, and over the history we have for it it has declined 76.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4050 per GM |
|---|---|
| All-time high | $1.9202 (Oct 16, 2019) |
| All-time low | $0.2433 (Nov 20, 2024) |
| 52-week high | $0.4493 |
| 52-week low | $0.3054 |
| Median price | $0.4681 |
| Average price | $0.6253 |
| Largest weekly change | +56.1% (Jun 19, 2024) |
| Weeks tracked | 387 |
| Tracking since | May 8, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clobetasol propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL PROP 0.05% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL PROP 0.05% FOAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.4050 per GM (NDC 68462060827), effective Sep 30, 2026.
How has the price of CLOBETASOL PROP 0.05% FOAM changed over time?
Over the history we have for it, the NADAC for CLOBETASOL PROP 0.05% FOAM has declined 76.2%. It has been tracked across 387 weekly CMS publications since May 8, 2019.
What are the highest and lowest recorded NADAC prices for CLOBETASOL PROP 0.05% FOAM?
Since May 8, 2019, the NADAC for CLOBETASOL PROP 0.05% FOAM has ranged from a low of $0.2433 (Nov 20, 2024) to a high of $1.9202 (Oct 16, 2019), with a median of $0.4681 per GM.
Are there cheaper alternatives to CLOBETASOL PROP 0.05% FOAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL PROP 0.05% FOAM, is $0.3045 per GM — about 25% below CLOBETASOL PROP 0.05% FOAM.
Who manufactures CLOBETASOL PROP 0.05% FOAM?
CLOBETASOL PROP 0.05% FOAM (NDC 68462060827) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.